SIBOLD WILLIAM JOHN (President and CEO) sold 1.6% of their position (2.40K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.38M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/4/2025ACC: 0001628280-25-055430
DirectorOfficer· President and CEO
Since Mar 2026
-2.40K
Net shares
Net seller
$1.38M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 52.40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
48.8%
12/3/2025
102.47K→152.47K
Common Stock
Direct
Shares
−2.40K
Price / share
$575.34
Trade value
$1.38M
% of position
1.6%
12/4/2025
152.47K→150.07K
Total
Net shares
+47.60K
Net value
-$1.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/3/2025 | M · Option Exercise | +50K | — | — | 48.8% | 102.47K | 152.47K |
| Common Stock Direct | 12/4/2025 | S · Sale | −2.40K | $575.34 | $1.38M | 1.6% | 152.47K | 150.07K |
| Total | +47.60K | -$1.38M | ||||||
Derivative Transactions1
Performance Restricted Stock Units
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
Held after
0.00
Exercisable
—
12/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Restricted Stock Units Direct | Common Stock50K shares | 12/3/2025 | M · Option Exercise | −50K | — | 0.00 |